fbpx

New advisory board member, Fran Towey, former CEO of Fullscript

We are committed to Empowering people to advocate for their health and raise awareness for those living with kidney disease.

Santa Barbara Nutrients announces new advisory board
member, Fran Towey, former CEO of Fullscript

Santa Barbara, California – April 27th, 2022

Fran founded Bayberry Lane Partners LLC in 2022 after serving as Chairman and Chief Executive Offer of Fullscript, an Integrative Healthcare delivery platform. Prior to Fullscript he served as President and CEO of a leading private equity owned company in the professional health and wellness industry. Fran earned a BS in Mechanical Engineering from Northeastern University, in Boston, MA and an Executive MBA from Fogelman College of Business and Economics at the University of Memphis.

He also sits on the board of trustees for Southwest College of Naturopathic Medicine and Health Sciences, and is an advisor for Findway Ventures, a fund that guides impact entrepreneurs on the great adventure of using business to make a positive difference in the world, and he is a former trustee at the Polycystic Kidney Disease Foundation.

Towey remarked, “PKD is deeply personal to me. As is often the case with PKD, it’s a family affair. I’m affected by ADPKD, as well as my mother, my siblings, and one of my children. The good work being done by the Santa Barbara Nutrients team aligns perfectly with my commitment to advocacy and support of PKD, and I look forward to supporting their mission.”

About Santa Barbara Nutrients, Inc.

Santa Barbara Nutrients is a public benefit corporation incorporated in Delaware and headquartered in Santa Barbara, California. The experienced SBN team is composed of kidney researchers, patients, and other industry professionals dedicated to bringing to market novel medical foods and other innovative products to help people with polycystic kidney disease (PKD) and other renal diseases.

The company is committed to scientific and clinical research to develop science backed products that support human health and address significant unmet medical needs.

For more information, please visit www.SantaBarbaraNutrients.com

Contact:

Email: Info@SantaBarbaraNutrients.com

Phone: 1+805-272-0029

New advisory board member, Chris Leamon, leader in clinical research

We are committed to Empowering people to advocate for their health and raise awareness for those living with kidney disease.

Santa Barbara Nutrients announces new advisory board
member, Chris Leamon, leader in clinical research

Santa Barbara, California – March 23rd, 2022

 

Dr. Leamon earned an ACS-certified B.S. degree in Chemistry from Baldwin Wallace University and a Ph.D. in Chemistry from Purdue University. He began his professional career in the pharmaceutical industry where he conducted targeted drug delivery research in the fields of peptide, oligonucleotide, liposome and DNA drug delivery for GlaxoSmithKline, Inc. and Ionis Pharmaceuticals. 

He later helped to establish Endocyte, Inc. where he was a named executive officer. While there he led the Company’s targeted drug discovery division, which included oncology, inflammation and polycystic kidney disease programs, for 20 years until its 2018 acquisition by Novartis.  Following a 3-year integration, Dr. Leamon left Novartis to become Chief Scientific Officer at Fusion Pharmaceuticals to help advance a diverse pipeline of targeted radiopharmaceuticals for cancer therapy. 

Dr. Leamon has published over 90 articles and is an inventor on more than 60 issued or submitted patents. Importantly, in 2015 he was the recipient of the 2015 American Chemical Society, George and Christine Sosnovsky Award for Cancer Research. To date, Dr. Leamon’s efforts have yielded 8 clinically investigated imaging and therapeutic agents for the treatment of cancer.

About Santa Barbara Nutrients, Inc.

Santa Barbara Nutrients is a public benefit corporation incorporated in Delaware and headquartered in Santa Barbara, California. The experienced SBN team is composed of kidney researchers, patients, and other industry professionals dedicated to bringing to market novel medical foods and other innovative products to help people with polycystic kidney disease (PKD) and other renal diseases.

The company is committed to scientific and clinical research to develop science backed products that support human health and address significant unmet medical needs.

For more information, please visit www.SantaBarbaraNutrients.com

Contact:

Email: Info@SantaBarbaraNutrients.com

Phone: 1+805-272-0029

Urine pH and Kidney Disease

 

 

In this video, Santa Barbara Nutrients President and UCSB Professor Thomas Weimbs, PhD, discusses how to measure urinary pH, why it’s important for individuals with kidney disease to monitor their urinary pH, and the effects of diet on urinary pH. Santa Barbara Nutrients also announces its sponsorship at the Metabolic Health Summit.

 

Urinary pH is important to monitor for those who have kidney disease. The urine pH can vary considerably depending on the kind of foods we eat and depending on certain health conditions. A perfectly neutral pH (neither acidic nor alkaline) has a value of 7. Most people in industrialized societies have acidic urine pH (for example, around pH 5 which is 100x more acidic than pH 7) due to the high consumption of acidifying foods such as grains and animal protein (meats, dairy, eggs). Furthermore, many health conditions can affect the urine pH. For example, individuals with chronic kidney disease frequently have acidic urine pH. If the urine pH is too acidic or too alkaline, there is a higher risk that microscopic crystals can form that can damage kidneys and can also lead to kidney stones. For example, acidic urine pH increases the risk of forming crystals and stones composed of calcium oxalate, uric acid, or cystine. A urine pH value near neutral (around pH 6-7.5) is ideal for most people unless they have been told by their healthcare practitioner that their urine pH should have a different value.

 

Thomas Weimbs, PhD discusses:

– Why it is important for individuals with kidney disease to monitor the pH of their urine

– The relationship between urinary pH and kidney stones

– What the ideal pH range of urine samples is and why

– How to measure urine pH – How often one should measure urine pH

– The best time to measure urine pH

– What low and high urinary pH means

 

pH urinary protocol: https://santabarbaranutrients.com/wp-…

 

pH paper: https://store.santabarbaranutrients.c…

 

SBN: https://santabarbaranutrients.com/

 

Metabolic Health Summit https://metabolichealthsummit.com/

 

Please ALWAYS consult your doctor before changing your diet or taking supplements or medication. The posts and discussions in this video do not constitute medical advice. Please consult with your own health care professional regarding any changes you would like to make to your own health care plan.

First Medical Food for Dietary Management of PKD Launched

We are committed to Empowering people to advocate for their health and raise awareness for those living with kidney disease.

First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched

The first-of-its-kind product, named KetoCitraTM, is based on breakthrough research by University of California Santa Barbara professor Dr. Thomas Weimbs, a recognized leader in the Polycystic Kidney Disease (PKD) research field, and Dr. Jacob Torres, Head Researcher of Santa Barbara Nutrients (SBN).

Santa Barbara, California – December 6th, 2021

The patented technology underlying KetoCitraTM was initially developed by Dr. Weimbs and Dr. Torres at the University of California, Santa Barbara. They discovered that a combination of two  natural compounds – beta-hydroxybutyrate (BHB) and citrate – has a synergistic effect in halting  or slowing the progression of PKD in animal models.

With kidney health and safety as a priority during the product’s development, SBN worked with a premier group of advisors that included some of the leading scientists, medical doctors and  dietitians in the renal field worldwide.

“The launch of KetoCitraTM is a seminal moment for both Santa Barbara Nutrients and PKD  patients. Our focus is to bring hope to the millions of PKD patients around the world, and we  think KetoCitraTM has the potential to achieve that,” said Dr. Weimbs, President and Founder  of Santa Barbara Nutrients.

What is polycystic kidney disease?

PKD is one of the most common, life-threatening genetic diseases, causing kidney enlargement  and function loss over time. The disease affects over 600,000 Americans and 13 million people  worldwide and is one of the leading causes of kidney failure requiring dialysis or kidney  transplantation. There is no cure.

About KetoCitra TM

The research by Dr. Weimbs and Dr. Torres showed that two natural compounds, beta hydroxybutyrate (BHB) and citric acid (citrate), can help the nutritional management of PKD by  addressing the metabolic abnormalities that manifest during the progression of the disease.

KetoCitraTM is specifically designed with these two ingredients in a formulation that also delivers  beneficial minerals and an alkaline load intended to support the balancing of urine pH. The  inclusion of calcium and magnesium helps to manage the dietary absorption of the renal  stressors oxalate and inorganic phosphate.

KetoCitraTM uses only ingredients that are generally recognized as safe (GRAS), is sodium- and  sugar-free and formulated to be kidney-safe when used as directed. As a medical food,  KetoCitraTM is to be taken under medical supervision. KetoCitraTM can be taken by itself but is  recommended to be taken in conjunction with specific dietary and lifestyle changes. Researchers at SBN have collaborated with experienced renal dietitians to create a dietary program called Ren.Nu that is administered by the non-profit RenAlign. Patients in the Ren.Nu  program, which launches in January 2022, learn to implement a plant-focused, kidney-safe  ketogenic diet, together with KetoCitraTM, in a sustainable way.

About Santa Barbara Nutrients, Inc.  

Santa Barbara Nutrients is a public benefit corporation incorporated in Delaware and  headquartered in Santa Barbara, California. The experienced SBN team is composed of kidney  researchers, patients, and other industry professionals dedicated to bringing to market novel  medical foods and other innovative products to help people with PKD and other renal diseases.

The company is committed to scientific and clinical research to develop science backed  products that support human health and address significant unmet medical needs.

For more information, please visit www.SantaBarbaraNutrients.com

Want to read more? https://www.news.ucsb.edu/2021/020480/ketocitra-here

Contact:

Email: Info@SantaBarbaraNutrients.com

Phone: 1+805-272-0029

Polycystic Kidney Disease (PKD) and Oxalates – Interview with Sally Norton

Polycystic Kidney Disease (PKD) and Oxalates - Interview with Sally Norton

 

Dr. Jacob Torres, Head Researcher at Santa Barbara Nutrients interviews oxalate expert and health consultant Sally Norton, MPH. Sally has 35 years of health education and research and is passionate about helping individuals eat for vitality and long-term health.

During this interview, Sally discusses how oxalates are processed in the body, the effects of high oxalate foods for patients with chronic kidney disease (CKD), and why it is important for people with CKD to monitor their oxalate intake.

In this video, Sally Norton, MPH discusses: 

What is oxalate and why is it bad for us? 

-Oxalates and the gut?

-What happens from eating too many oxalates?

-Lost seasonality and high oxalate foods? 

-How to remove oxalate but not all at once?

-What can people do now with oxalate consumption?

 

 

 

 

 

To view the full video, please visit: https://www.youtube.com/watch?v=rQXEYZuYpN0&t=4s